Total Payments
$16,738
2024 Payments
$306.55
Companies
29
Transactions
306
Medicare Patients
526
Medicare Billing
$49,283
Payment Breakdown by Category
Research$8,450 (50.5%)
Food & Beverage$5,951 (35.6%)
Consulting$2,310 (13.8%)
Education$27.53 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $8,450 | 1 | 50.5% |
| Food and Beverage | $5,951 | 301 | 35.6% |
| Consulting Fee | $2,310 | 1 | 13.8% |
| Education | $27.53 | 3 | 0.2% |
Payments by Type
Research
$8,450
1 transactions
General
$8,288
305 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $10,806 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,510 | 71 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,018 | 33 | $0 (2024) |
| Lilly USA, LLC | $552.81 | 39 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $386.74 | 14 | $0 (2022) |
| Amgen Inc. | $353.61 | 22 | $0 (2023) |
| ABBVIE INC. | $346.98 | 19 | $0 (2024) |
| Novo Nordisk Inc | $304.16 | 17 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $280.41 | 27 | $0 (2017) |
| Allergan, Inc. | $185.03 | 5 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $306.55 | 13 | GlaxoSmithKline, LLC. ($161.31) |
| 2023 | $364.10 | 17 | GlaxoSmithKline, LLC. ($139.88) |
| 2022 | $872.91 | 40 | AstraZeneca Pharmaceuticals LP ($354.78) |
| 2021 | $3,535 | 66 | Abbott Laboratories ($2,310) |
| 2020 | $760.44 | 32 | AstraZeneca Pharmaceuticals LP ($323.95) |
| 2019 | $477.03 | 14 | GlaxoSmithKline, LLC. ($257.50) |
| 2018 | $9,139 | 36 | Abbott Laboratories ($8,450) |
| 2017 | $1,283 | 88 | Lilly USA, LLC ($329.17) |
All Payment Transactions
306 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $108.38 | General |
| Category: RESPIRATORY | ||||||
| 08/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: NEUROSCIENCE | ||||||
| 08/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Neurology | ||||||
| 07/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Diabetes Care | ||||||
| 07/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/14/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.73 | General |
| 05/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: RESPIRATORY | ||||||
| 04/19/2024 | Phadia US Inc. | ImmunoCAP (Device) | Food and Beverage | Cash or cash equivalent | $17.90 | General |
| Category: Allergy/Immunology | ||||||
| 04/18/2024 | Hologic Sales and Service, LLC | APTIMA (Device), THINPREP 2000 PROCESSOR | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Diagnostics | ||||||
| 04/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.29 | General |
| 02/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.39 | General |
| Category: PSYCHIATRY | ||||||
| 11/27/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.75 | General |
| Category: Diabetes Care | ||||||
| 09/28/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: Inflammation | ||||||
| 07/11/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Diabetes | ||||||
| 06/22/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.78 | General |
| 06/06/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: RESPIRATORY | ||||||
| 04/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: RESPIRATORY | ||||||
| 04/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $2.43 | General |
| Category: RESPIRATORY | ||||||
| 04/10/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/22/2023 | Hologic Sales and Service, LLC | APTIMA (Device), THINPREP 2000 PROCESSOR, AFFIRM PRONE BIOPSY SYSTEM | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Diagnostics | ||||||
| 03/22/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Inflammation | ||||||
| 03/10/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.06 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Optisure Lead Post Approval Study | Abbott Laboratories | $8,450 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 48 | 53 | $4,351 | $1,581 |
| 2021 | 12 | 274 | 550 | $52,486 | $29,795 |
| 2020 | 8 | 204 | 381 | $39,902 | $17,907 |
Total Patients
526
Total Services
984
Medicare Billing
$49,283
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 26 | $4,238 | $1,508 | 35.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 16 | 16 | $80.00 | $48.00 | 60.0% |
| 81003 | Automated urinalysis test | Office | 2022 | 11 | 11 | $33.00 | $24.75 | 75.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 60 | 213 | $34,708 | $20,518 | 59.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 28 | 61 | $6,824 | $3,738 | 54.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 15 | 15 | $2,574 | $1,977 | 76.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 12 | 12 | $2,978 | $1,178 | 39.6% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2021 | 22 | 26 | $2,321 | $828.92 | 35.7% |
| 86328 | Test for detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody, qualitative or semiquantitative | Office | 2021 | 14 | 16 | $1,120 | $723.68 | 64.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 21 | 56 | $1,230 | $574.66 | 46.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 32 | 48 | $240.00 | $144.00 | 60.0% |
| 81003 | Automated urinalysis test | Office | 2021 | 26 | 30 | $104.00 | $67.50 | 64.9% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2021 | 11 | 22 | $66.00 | $29.76 | 45.1% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2021 | 13 | 27 | $81.00 | $10.42 | 12.9% |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | Office | 2021 | 20 | 24 | $240.00 | $4.27 | 1.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 55 | 126 | $20,200 | $9,678 | 47.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 41 | 104 | $11,480 | $5,323 | 46.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $4,250 | $1,756 | 41.3% |
| 94060 | Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration | Office | 2020 | 11 | 12 | $1,752 | $505.04 | 28.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 20 | 46 | $1,794 | $473.34 | 26.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 35 | 50 | $250.00 | $149.16 | 59.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2020 | 12 | 12 | $36.00 | $19.35 | 53.8% |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | Office | 2020 | 13 | 14 | $140.00 | $2.48 | 1.8% |
About Dr. Jorge Diaz, M.D
Dr. Jorge Diaz, M.D is a General Practice healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2015. The National Provider Identifier (NPI) number assigned to this provider is 1699157180.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jorge Diaz, M.D has received a total of $16,738 in payments from pharmaceutical and medical device companies, with $306.55 received in 2024. These payments were reported across 306 transactions from 29 companies. The most common payment nature is "" ($8,450).
As a Medicare-enrolled provider, Diaz has provided services to 526 Medicare beneficiaries, totaling 984 services with total Medicare billing of $49,283. Data is available for 3 years (2020–2022), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Location Tampa, FL
- Active Since 06/22/2015
- Last Updated 03/28/2019
- Taxonomy Code 208D00000X
- Entity Type Individual
- NPI Number 1699157180
Products in Payments
- Optisure Lead (Device) $8,450
- Accent Pacemaker (Device) $2,310
- TRELEGY ELLIPTA (Drug) $550.54
- FARXIGA (Drug) $530.92
- BREZTRI (Drug) $519.45
- TRADJENTA (Drug) $226.07
- VRAYLAR (Drug) $219.67
- INVOKANA (Drug) $175.16
- Kerendia (Drug) $169.37
- ANORO ELLIPTA (Drug) $153.22
- TRULICITY (Drug) $151.22
- NAMENDA XR (Drug) $139.42
- BREZTRI AEROSPHERE (Drug) $139.04
- EVENITY (Biological) $131.83
- EMGALITY (Drug) $121.43
- FASENRA (Biological) $108.47
- AREXVY (Drug) $108.38
- XARELTO (Drug) $105.25
- Otezla (Drug) $102.46
- BASAGLAR (Drug) $99.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Tampa
Dr. Sarah Jockin, Dds, DDS
General Practice — Payments: $366,051
General Practice $366,051
Dr. William Torres Perez, M.d, M.D
General Practice — Payments: $82,552
General Practice $82,552
Jeffrey Hunt, Do, DO
General Practice — Payments: $76,793
General Practice $76,793
Dr. David Goldschein, D.d.s, D.D.S
General Practice — Payments: $25,125
General Practice $25,125
Dr. Matthew Waite, D.d.s, D.D.S
General Practice — Payments: $15,978
General Practice $15,978
Dr. Darshanand Persaud, Dmd, DMD
General Practice — Payments: $8,257
General Practice $8,257